• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR

NYRADA INC.

0.00% ! 30.0¢
Market Cap $63.43M  !

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NYR
CHART
2 3 4
08/08/25 194 36K
08/08/25 Last post  Bendunstan Comments Created with Sketch.  194  Views Created with Sketch.  36K 
NYR 08/08/25 144 38K
08/08/25 Last post  420247 Comments Created with Sketch.  144  Views Created with Sketch.  38K 
NYR 06/08/25 93 23K
06/08/25 Last post  Bendunstan Comments Created with Sketch.  93  Views Created with Sketch.  23K 
NYR 06/08/25 7 1.7K
06/08/25 Last post  renn11 Comments Created with Sketch.  7  Views Created with Sketch.  1.7K 
NYR 06/08/25 0 266
06/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  266 
NYR 05/08/25 5 1.4K
05/08/25 Last post  Bendunstan Comments Created with Sketch.  5  Views Created with Sketch.  1.4K 
NYR 05/08/25 48 13K
05/08/25 Last post  Bendunstan Comments Created with Sketch.  48  Views Created with Sketch.  13K 
NYR 04/08/25 0 215
04/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  215 

See All Discussions arrow Created with Sketch.

Timeline

Positive Final Review of Nyrada Phase I Clinical Trial
06 Aug 09:38
 
BioShares Biotech Summit Presentation
06 Aug 08:24
 
Change in substantial holding - M Azzi
05 Aug 10:25
 
Cleansing Statement
04 Aug 11:15
 
Application for quotation of securities - NYR
04 Aug 11:13
 
Application for quotation of securities - NYR
04 Aug 11:10
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $63.43M
Open High Low Value Volume
30.0¢ 30.0¢ 29.0¢ $245.6K 829.7K

Buyers (Bids)

No. Vol. Price($)
2 29101 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 311729 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.